Gabriele Pollara"๐๐ฐ๐ฏ-๐ข๐ฏ๐ต๐ช๐ฃ๐ช๐ฐ๐ต๐ช๐ค ๐ด๐ต๐ณ๐ข๐ต๐ฆ๐จ๐ช๐ฆ๐ด ๐ฅ๐ฐ ๐ฐ๐ฏ๐ฆ ๐ต๐ฉ๐ช๐ฏ๐จ ๐ฑ๐ข๐ณ๐ต๐ช๐ค๐ถ๐ญ๐ข๐ณ๐ญ๐บ ๐ธ๐ฆ๐ญ๐ญ: ๐ต๐ฉ๐ฆ๐บ ๐ณ๐ฆ๐ฅ๐ถ๐ค๐ฆ ๐ต๐ฉ๐ฆ ๐ฐ๐ท๐ฆ๐ณ๐ข๐ญ๐ญ ๐ฏ๐ถ๐ฎ๐ฃ๐ฆ๐ณ ๐ฐ๐ง ๐ข๐ฏ๐ต๐ช๐ฃ๐ช๐ฐ๐ต๐ช๐ค๐ด ๐ฑ๐ณ๐ฆ๐ด๐ค๐ณ๐ช๐ฃ๐ฆ๐ฅ ๐ข๐ฏ๐ฅ ๐ข๐ฅ๐ฎ๐ช๐ฏ๐ช๐ด๐ต๐ฆ๐ณ๐ฆ๐ฅ."
A point well made ๐ but evidence for efficacy also not established. Maybe what we really need is to better identify patients who'll progress to urosepsis. And others will get better by themselves? ๐คท
@ESCMID #UTI #recurrentUTI #antibiotics #microbiology #AMR #MedMastodon #IDMastodon https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(23)00276-8/fulltext?dgcid=raven_jbs_aip_email
